Vital Signs - Will Advanced Image Fusion Software Trump Hybrid MR/PET Scanners?

 


This issue of Vital Signs, released on March 16, 2009, provides a strategic overview of the adoption of image fusion software possibly surpassing MR/PET, and which sectors offer alternative growth opportunities for MR/PET. Additionally, a company spotlight is provided for Serica Technologies, Inc., a company developing silk-based biomaterial platforms that may be used for tissue repair and regeneration applications in orthopedics and sports medicine. Reimbursement and regulatory news from the FDA is also provided for the week of March 2, 2009.
USD 1,500

* Required Fields

USD 1,500

PAY BY INVOICE

Be the first to review this product

Table of Contents

Vital Signs - Will Advanced Image Fusion Software Trump Hybrid MR/PET Scanners?Vital Signs: 16 March 2009This week's issue:




Related Research

Release Date : 08-Aug-17

Region : North America

Release Date : 31-Jul-17

Region : North America

Release Date : 27-Jul-17

Region : North America

Release Date : 27-Jul-17

Region : North America

Release Date : 24-Jul-17

Region : North America

Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.